Skip to main content
. 2011 Aug 31;6(8):e23631. doi: 10.1371/journal.pone.0023631

Figure 1. Kaplan Meier survival curve showing death non-censored graft survival for the presence or absence of HLA-C2 allele in the recipient.

Figure 1

The presence of an HLA-C2 allele in the recipient was associated with a significant improvement in death non-censored graft survival (10-year survival: 65.7% versus 43.8%).